Virtu Financial’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
Other funds holding PACB
AIM
EDRH
NAMA
MA
Virtu Financial's PACB Position: Q3 2025 in Review
Virtu Financial sold out of Pacific Biosciences (PACB) in Q3 2025, closing a stake of 205,780 shares — an estimated $255K sold.
Virtu Financial first reported a position in PACB in Q3 2017 and held it in 12 quarters. The position peaked at $599K in Q3 2021. 208 funds tracked by Wall St. Rank hold PACB as of Q3 2025.
- Virtu Financial reported no remaining Pacific Biosciences position as of Q3 2025 after selling out during the quarter.
- Virtu Financial sold 205,780 Pacific Biosciences shares in Q3 2025, an estimated $255K.
- Virtu Financial first reported a position in Pacific Biosciences in Q3 2017 and held it in 12 quarters.
- Virtu Financial's Pacific Biosciences position peaked at $599K in Q3 2021.
- 208 funds tracked by Wall St. Rank held Pacific Biosciences as of Q3 2025.
Based on Virtu Financial's 13F filing for Q3 2025, filed 14 Nov 2025.